Everolimus in de novo liver transplant recipients： a systematic review

BACKGROUND： Everolimus has no nephrotoxicity and is used to treat patients with post-liver transplant chronic renal insufficiency. The present systematic review was to evaluate the efficacy and safety of everolimus in de novo liver transplant patients.DATA SOURCES： Randomized controlled trials compa...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Hepatobiliary & pancreatic diseases international 2015-10, Vol.14 (5), p.461-469
Hauptverfasser:	Tang, Cheng-Yong, Shen, Ai, Wei, Xu-Fu, Li, Qing-Dong, Liu, Rui, Deng, He-Jun, Wu, Yong-Zhong, Wu, Zhong-Jun
Format:	Artikel
Sprache:	eng
Schlagworte:	calcineurin inhibitors Calcineurin Inhibitors - administration & dosage CNIs Drug Therapy, Combination Endocrinology & Metabolism everolimus Everolimus - adverse effects Everolimus - therapeutic use Gastroenterology and Hepatology Graft Rejection - drug therapy Graft Rejection - pathology Humans Immunosuppressive Agents - adverse effects Immunosuppressive Agents - therapeutic use Liver Neoplasms - prevention & control Liver Transplantation Meta分析 Neoplasm Recurrence, Local - prevention & control Randomized Controlled Trials as Topic Renal Insufficiency, Chronic - physiopathology systematic review 可信区间系统肝移植肾功能不全肾小球滤过率随机对照试验
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!